{"id":"https://openalex.org/W2484493814","doi":"https://doi.org/10.1158/1940-6215.prev-13-a13","title":"Abstract A13: Mechanism-based chemoprevention of triple-negative breast cancer by blockade at multiple cell cycle regulatory points","display_name":"Abstract A13: Mechanism-based chemoprevention of triple-negative breast cancer by blockade at multiple cell cycle regulatory points","publication_year":2013,"publication_date":"2013-11-01","ids":{"openalex":"https://openalex.org/W2484493814","doi":"https://doi.org/10.1158/1940-6215.prev-13-a13","mag":"2484493814"},"language":"en","primary_location":{"id":"doi:10.1158/1940-6215.prev-13-a13","doi":"https://doi.org/10.1158/1940-6215.prev-13-a13","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1940-6215.prev-13-a13","pdf_url":null,"source":{"id":"https://openalex.org/S68240649","display_name":"Cancer Prevention Research","issn_l":"1940-6207","issn":["1940-6207","1940-6215"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Prevention Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5077225386","display_name":"Beate C. Litzenburger","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Beate C. Litzenburger","raw_affiliation_strings":["The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056216710","display_name":"Iv\u00e1n P. Uray","orcid":"https://orcid.org/0000-0002-3702-7608","observed_orcids":["https://orcid.org/0000-0002-3702-7608"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ivan P. Uray","raw_affiliation_strings":["The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043733113","display_name":"Jamal L. Hill","orcid":"https://orcid.org/0000-0002-7828-9647","observed_orcids":["https://orcid.org/0000-0002-7828-9647"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jamal Hill","raw_affiliation_strings":["The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042960706","display_name":"Khandan Keyomarsi","orcid":"https://orcid.org/0000-0002-5440-0849","observed_orcids":["https://orcid.org/0000-0002-5440-0849"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Khandan Keyomarsi","raw_affiliation_strings":["The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5069756775","display_name":"Powel H. Brown","orcid":"https://orcid.org/0000-0002-3398-163X","observed_orcids":["https://orcid.org/0000-0002-3398-163X"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Powel H. Brown","raw_affiliation_strings":["The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I1343551460"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"6","issue":"11_Supplement","first_page":"A13","last_page":"A13"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11559","display_name":"Retinoids in leukemia and cellular processes","score":0.33719998598098755,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11559","display_name":"Retinoids in leukemia and cellular processes","score":0.33719998598098755,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10583","display_name":"Cancer-related Molecular Pathways","score":0.2304999977350235,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.1956000030040741,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/triple-negative-breast-cancer","display_name":"triple-negative breast cancer","score":0.9959999918937683},{"id":"https://openalex.org/keywords/chemoprevention","display_name":"chemoprevention","score":0.9509999752044678},{"id":"https://openalex.org/keywords/rexinoids","display_name":"rexinoids","score":0.8560000061988831},{"id":"https://openalex.org/keywords/lg100268","display_name":"LG100268","score":0.9869999885559082},{"id":"https://openalex.org/keywords/retinoid-x-receptor","display_name":"retinoid X receptor","score":0.8360000252723694},{"id":"https://openalex.org/keywords/kinase-inhibitors","display_name":"kinase inhibitors","score":0.5189999938011169},{"id":"https://openalex.org/keywords/kinome","display_name":"kinome","score":0.5950000286102295},{"id":"https://openalex.org/keywords/cell-cycle-regulation","display_name":"cell cycle regulation","score":0.7379999756813049},{"id":"https://openalex.org/keywords/cyclin-d","display_name":"cyclin D","score":0.6330000162124634},{"id":"https://openalex.org/keywords/telomerase","display_name":"telomerase","score":0.5049999952316284},{"id":"https://openalex.org/keywords/mammary-epithelial-cells","display_name":"mammary epithelial cells","score":0.718999981880188},{"id":"https://openalex.org/keywords/p53-null-mice","display_name":"p53-null mice","score":0.859000027179718}],"concepts":[{"id":"https://openalex.org/C2780110267","wikidata":"https://www.wikidata.org/wiki/Q7843332","display_name":"Triple-negative breast cancer","level":4,"score":0.8136129379272461},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6518811583518982},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.6203992962837219},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.5998484492301941},{"id":"https://openalex.org/C2780234812","wikidata":"https://www.wikidata.org/wiki/Q1787013","display_name":"Cancer prevention","level":3,"score":0.5650102496147156},{"id":"https://openalex.org/C54174078","wikidata":"https://www.wikidata.org/wiki/Q3197188","display_name":"Kinome","level":3,"score":0.5165895223617554},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5064965486526489},{"id":"https://openalex.org/C2777329042","wikidata":"https://www.wikidata.org/wiki/Q420323","display_name":"Lapatinib","level":5,"score":0.4721294045448303},{"id":"https://openalex.org/C96232424","wikidata":"https://www.wikidata.org/wiki/Q4118072","display_name":"Cancer cell","level":3,"score":0.4129719138145447},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.39171040058135986},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.3868609368801117},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.32432693243026733},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2764262557029724},{"id":"https://openalex.org/C2779786085","wikidata":"https://www.wikidata.org/wiki/Q412616","display_name":"Trastuzumab","level":4,"score":0.08243018388748169},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1940-6215.prev-13-a13","doi":"https://doi.org/10.1158/1940-6215.prev-13-a13","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1940-6215.prev-13-a13","pdf_url":null,"source":{"id":"https://openalex.org/S68240649","display_name":"Cancer Prevention Research","issn_l":"1940-6207","issn":["1940-6207","1940-6215"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Prevention Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2468102407","https://openalex.org/W4313590330","https://openalex.org/W4386799949","https://openalex.org/W1967790739","https://openalex.org/W4415513683","https://openalex.org/W2129746143","https://openalex.org/W7130731002","https://openalex.org/W2117173730","https://openalex.org/W2326249637","https://openalex.org/W2121478012"],"abstract_inverted_index":{"Abstract":[0,575],"Effective":[1],"chemoprevention":[2,532],"strategies":[3],"currently":[4],"only":[5],"target":[6,110],"the":[7,36,66,88,133,138,209,214,248,302,332,394,398,420,440,489,549],"development":[8],"of":[9,26,38,68,92,99,103,132,162,179,213,247,258,281,301,318,331,378,388,397,439,453,483,497,533,548],"ER-positive":[10],"breast":[11,19,28,71,180,476,535],"cancer,":[12],"but":[13,157],"do":[14],"not":[15],"prevent":[16,473],"triple":[17,69,474],"negative":[18,70,276,475],"cancer":[20,128,196,210,536],"(TNBC)":[21],"which":[22,78],"represents":[23],"approximately":[24],"20%":[25],"all":[27],"cancers.":[29,93],"TNBC":[30,163,195,443,484,498],"mostly":[31],"affects":[32],"young":[33],"women":[34],"and":[35,62,75,90,115,166,205,253,288,296,325,339,345,380,391,402,410,435,486,508],"standard":[37],"care":[39],"therapy":[40,494],"(highly":[41],"cytotoxic":[42],"chemotherapy)":[43],"is":[44,55,137,146,468],"too":[45],"toxic":[46],"to":[47,59,207,354,359,472,491],"use":[48,101],"as":[49,126,275,460],"a":[50,56,223,271,312,469],"prevention":[51,67,89,197,496],"strategy.":[52],"Therefore,":[53],"there":[54],"critical":[57],"need":[58],"identify":[60,217],"effective":[61,148,194,376],"tolerable":[63],"drugs":[64,107],"for":[65,87,334,495],"cancer.":[72,477],"Naturally":[73],"occurring":[74,96],"synthetic":[76],"retinoids,":[77],"are":[79,98,123],"vitamin":[80],"A":[81,316],"analogues,":[82],"have":[83,142,171],"been":[84],"successfully":[85],"used":[86],"treatment":[91],"However,":[94],"naturally":[95],"retinoids":[97],"limited":[100],"because":[102],"their":[104],"toxicity.":[105],"Thus,":[106],"that":[108,144,175,192,308,451],"specifically":[109],"RXR":[111,117],"nuclear":[112,121],"receptors":[113,122],"(\u201crexinoids\u201d)":[114],"activate":[116],"without":[118],"activating":[119],"RAR":[120],"being":[124],"studied":[125],"potential":[127],"preventive":[129,159,211],"drugs.":[130],"One":[131],"most":[134],"promising":[135,470],"rexinoids":[136,176],"compound,":[139],"LG100268.":[140,400],"We":[141,170],"demonstrated":[143,174],"LG100268":[145,206,232,326,427],"highly":[147,375],"in":[149,154,160,229,233,256,268,328,348,424,433,446,557],"preventing":[150],"ER-negative/HER2-positive":[151],"mammary":[152,236,430],"tumors":[153],"MMTV-ErbB2":[155],"mice,":[156],"less":[158],"models":[161],"(p53-null":[164],"mice":[165],"C3(1)-SV40":[167,441],"Tag":[168,442],"mice).":[169],"also":[172,487],"previously":[173],"suppress":[177],"growth":[178,282,335,383,432],"cells":[181,238,283],"by":[182,201,293,323,463,504,537],"inhibiting":[183],"cyclin":[184,465],"D-dependent":[185],"pathways.":[186,413],"For":[187],"this":[188],"study,":[189],"we":[190,220],"hypothesized":[191],"more":[193],"could":[198],"be":[199],"achieved":[200],"combining":[202],"kinase":[203],"inhibitors":[204,415],"enhance":[208,480],"effect":[212,396],"rexinoid.":[215],"To":[216],"such":[218,459],"kinases":[219,252,320],"carried":[221,346],"out":[222],"\u2018whole":[224],"kinome\u2019":[225],"high-throughput":[226],"siRNA":[227,243,273,324,338,418],"screen":[228,265],"combination":[230,425,493],"with":[231,270,286,337,352,368,426],"immortalized,":[234],"human":[235,251],"epithelial":[237,431],"overexpressing":[239],"telomerase":[240],"(HME-hTert).":[241],"The":[242,264],"library":[244],"targets":[245],"each":[246],"636":[249],"known":[250],"was":[254,266,291],"arrayed":[255],"pools":[257],"three":[259],"individual":[260],"siRNAs":[261,353],"per":[262],"kinase.":[263],"performed":[267],"quadruplicate,":[269],"non-targeting":[272],"pool":[274],"control.":[277],"After":[278],"4":[279],"days":[280],"were":[284,342,357,502],"stained":[285],"DAPI":[287],"cell":[289,405,455,541],"number":[290],"determined":[292],"automated":[294],"microscopy":[295],"image":[297],"analysis":[298],"(the":[299],"Z'-score":[300],"image-based":[303],"assays":[304],"exceeded":[305],"0.5,":[306],"suggesting":[307],"our":[309,481],"assay":[310],"had":[311],"robust":[313],"signal-to-noise":[314],"ratio).":[315],"total":[317],"41":[319],"whose":[321],"inhibition":[322,336,452],"resulted":[327],">":[329],"2SD":[330],"value":[333],"vehicle":[340],"alone":[341],"considered":[343,371],"\u201chits\u201d":[344],"forward":[347],"validation":[349],"studies.":[350],"Transfections":[351],"candidate":[355],"genes":[356],"repeated":[358],"confirm":[360],"gene":[361],"silencing":[362],"using":[363],"quantitative":[364],"real-time":[365],"PCR":[366],"(qRT-PCR),":[367],"\u226570%":[369],"knockdown":[370,387],"acceptable.":[372],"Results":[373],"showed":[374],"knock-down":[377],"candidates":[379],"confirmed":[381],"enhanced":[382,393],"suppression.":[384],"In":[385],"particular":[386],"CDK1,":[389],"2":[390,403],"5":[392],"chemopreventive":[395],"rexinoid":[399],"CDK1":[401],"regulate":[404],"cycle":[406,456,542],"through":[407],"Cyclin":[408,411],"B-":[409],"E-dependent":[412],"CDK":[414,421],"(either":[416],"CDKs":[417],"or":[419],"inhibitor":[422],"Dinaciclib)":[423],"additively":[428],"suppressed":[429],"vitro":[434],"hyperplastic":[436],"nodule":[437],"formation":[438],"mouse":[444],"model":[445],"vivo.":[447],"These":[448,478,500],"results":[449,479],"suggest":[450],"multiple":[454,540],"regulatory":[457,543],"points,":[458],"those":[461],"controlled":[462],"distinct":[464],"dependent":[466],"kinases,":[467],"strategy":[471],"understanding":[482],"tumorigenesis":[485],"provide":[488],"foundation":[490],"develop":[492],"development.":[499],"studies":[501],"supported":[503],"an":[505],"NCI":[506,509],"R01":[507],"R25T":[510],"grant":[511],"(RO1CA078480,":[512],"PB;":[513],"R25CA057730,":[514],"BL)":[515],"Citation":[516],"Format:":[517],"Beate":[518],"C.":[519],"Litzenburger,":[520],"Ivan":[521],"P.":[522],"Uray,":[523],"Jamal":[524],"Hill,":[525],"Khandan":[526],"Keyomarsi,":[527],"Powel":[528],"H.":[529],"Brown.":[530],"Mechanism-based":[531],"triple-negative":[534],"blockade":[538],"at":[539],"points.":[544],"[abstract].":[545],"In:":[546],"Proceedings":[547],"Twelfth":[550],"Annual":[551],"AACR":[552],"International":[553],"Conference":[554],"on":[555],"Frontiers":[556],"Cancer":[558],"Prevention":[559],"Research;":[560],"2013":[561],"Oct":[562],"27-30;":[563],"National":[564],"Harbor,":[565],"MD.":[566],"Philadelphia":[567],"(PA):":[568],"AACR;":[569],"Can":[570],"Prev":[571],"Res":[572],"2013;6(11":[573],"Suppl):":[574],"nr":[576],"A13.":[577]},"counts_by_year":[],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2016-08-23T00:00:00"}